Vivienne L. Young

P.O. Box 56, 720 Cumberland St
Dunedin, OTA 9054, New Zealand

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

The MNV-1 protease-polymerase precursor cleaves a novel site in the NS1-2 protein.

The MNV-1 protease-polymerase precursor cleaves a novel site in the NS1-2 protein.

Journal: The Journal of general virology

Published: April 29, 2026

Broad-Spectrum Peptidomimetic Inhibitors of Norovirus and Coronavirus 3C-like Proteases.

Broad-Spectrum Peptidomimetic Inhibitors of Norovirus and Coronavirus 3C-like Proteases.

Journal: ACS infectious diseases

Published: December 18, 2025

The Disorderly Nature of Caliciviruses.

The Disorderly Nature of Caliciviruses.

Journal: Viruses

Published: June 27, 2024

Murine Norovirus: Additional Protocols for Basic and Antiviral Studies.

Murine Norovirus: Additional Protocols for Basic and Antiviral Studies.

Journal: Current protocols

Published: July 21, 2023

Human Norovirus Triggers Primary B Cell Immune Activation In Vitro.

Human Norovirus Triggers Primary B Cell Immune Activation In Vitro.

Journal: mBio

Published: April 11, 2022

Akt Plays Differential Roles during the Life Cycles of Acute and Persistent Murine Norovirus Strains in Macrophages.

Akt Plays Differential Roles during the Life Cycles of Acute and Persistent Murine Norovirus Strains in Macrophages.

Journal: Journal of virology

Published: November 17, 2021

Norovirus VPg Binds RNA through a Conserved N-Terminal K/R Basic Patch.

Norovirus VPg Binds RNA through a Conserved N-Terminal K/R Basic Patch.

Journal: Viruses

Published: June 08, 2021

Delivering Two Tumour Antigens Survivin and Mucin-1 on Virus-Like Particles Enhances Anti-Tumour Immune Responses.

Delivering Two Tumour Antigens Survivin and Mucin-1 on Virus-Like Particles Enhances Anti-Tumour Immune Responses.

Journal: Vaccines

Published: March 29, 2021

Dry Formulation of Virus-Like Particles in Electrospun Nanofibers.

Dry Formulation of Virus-Like Particles in Electrospun Nanofibers.

Journal: Vaccines

Published: January 22, 2021

Felis catus papillomavirus type 2 virus-like particle vaccine is safe and immunogenic but does not reduce FcaPV-2 viral loads in adult cats.

Felis catus papillomavirus type 2 virus-like particle vaccine is safe and immunogenic but does not reduce FcaPV-2 viral loads in adult cats.

Journal: Veterinary immunology and immunopathology

Published: February 26, 2019

Functionalisation of Virus-Like Particles Enhances Antitumour Immune Responses.

Functionalisation of Virus-Like Particles Enhances Antitumour Immune Responses.

Journal: Journal of immunology research

Published: June 01, 2018

Adoptive cell therapy with CD4+ T helper 1 cells and CD8+ cytotoxic T cells enhances complete rejection of an established tumour, leading to generation of endogenous memory responses to non-targeted tumour epitopes.

Adoptive cell therapy with CD4+ T helper 1 cells and CD8+ cytotoxic T cells enhances complete rejection of an established tumour, leading to generation of endogenous memory responses to non-targeted tumour epitopes.

Journal: Clinical & translational immunology

Published: December 01, 2016

Showing 1-12 of 19

Last Updated: 09/26/2026